Skip to main content

Volatile Sensex, Nifty gain strength; Sun Pharma rallies

11:40am FII View: Mahesh Nandurkar, CLSA said interactions with 80 investors in the USA suggest FIIs' incremental interest in India is near a short-term peak. With most being overweight, there is an increasing unease about weak earnings, he added.

The brokerage still expects profit to improve, just not in the next couple of seasons, he said.

"The macro triggers of Land/GST bills also seem to be some time away. The structural story remains compelling for long-term investors but the risk of a near-term pullback is rising. We lower our weights on banks and capital goods," he explained.

11:25am Gammon Infra under pressure: Sebi refused to withdraw the ban on Abhijit Rajan, former CMD of Gammon Infrastructure Projects, from the securities market and said the prohibition will continue till further directions in a case related to insider trading.

The market regulator, in its order in July last year, had barred Rajan after prima-facie finding him to have violated insider trading regulations. This would be one of the few cases where CMD of a company has come under the scanner in an insider trading case.

In an order passed on Monday, Sebi has confirmed the directions issued in respect of Rajan vide ad-interim ex-parte order dated July 17, 2014. The directions issued vide the interim order "shall continue to be in force till further directions," it added.

11:00am Market Check:

The market remained firm with the Nifty bouncing back after 4 days of consecutive losses. The broader markets gained marginally more than the frontline indices with a firm advance:decline ratio.

The Sensex rose 109.22 points to 28301.24 and the Nifty advanced 31.20 points to 8582.10.

From the frontliners, Jindal Steel gained 2 percent on news of the Delhi High Court staying the transfer of Tara coal block and asking the government to file reasons for transferring the Gare-Palma IV 2 & 3 blocks by March 26.

Sun Pharma rallied 2 percent along with Ranbaxy Labs. The CCI approved Sun-Ranbaxy's plan to divest all 7 brands to Emcure Pharma. Strides Arcolab and Shasun Pharma too gained 3-5 percent as the CCI gave its approval to the proposed merger between the two entities. However, Aarti Drugs plunged 9 percent as the USFDA issued an import alert on the company's Palghar unit. More information please visit this site


Popular posts from this blog

Dark secrets of share market

Dark secrets of share market
Stock market has some dark secrets that no broker tells. And what is more surprising is that these secrets belong to the steps taken to make money.
Let’s see how positive things turn negative
1# Commodity price risk
When price of commodity escalates, it brings joy to the companies that see commodities as output. But for companies that see commodities as inputs see loss in increased. Companies that don’t deal in commodities also face difficulties with price escalation. It is so because the customers start selling commodities. And it won’t be an exaggeration to say that commodity pricing effects the entire economy.
2# Headline risk
Do you remember the news of Fukushima nuclear crisis? This news surfaced in 2011 and it drowned all the stocks related to businesses related to nuclear power like uranium miners. It is called headline risk and no business is free from this risk. A torrent ofnews-reports regarding a business can have an adverse effect on its commodity p…

Nifty could slip towards 9,900; 3 stocks which could give up to 11% return

A close beyond 10,400 levels with healthy volumes can pause the current bearishness triggering a short covering to levels of 10,640-10,730.

The Nifty index Futures continued to slide lower for the second month in a row making it 10 percent decline from the record highs. Further, it has broken down from a broadening wedge pattern along with a close below the 200-DMA, affirming weakness dominant in the markets at the moment.

A sustained trade below 10,050 can accelerate the fall to levels of 9,930-9,700. However, a close beyond 10,400 levels with healthy volumes can pause the current bearishness triggering a short covering to levels of 10,640-10,730.

Moreover, the relative strength index or the RSI has turned down from the neutral levels of 50 on two occasions in recent pullbacks suggesting further weakness in the coming trading sessions.

Here is the list of stocks which can give up to 11 percent return:

Arvind Ltd: SELL| Target Rs345| Stop Loss Rs410| Return 11%

On the weekly chart, Arv…

Reliance Infra arm moves Delhi HC over arbitration award against DMRC; stock up 5%

Subsidiary Delhi Airport Metro Express has moved the Delhi High Court seeking execution of the Arbitration award it had won against Delhi Metro Rail Corporation.
Reliance Infrastructure share price rallied 5 percent intraday Tuesday after the company's subsidiary DAMEPL has moved the Delhi High Court over the execution of Arbitration award against DMRC.

"...subsidiary Delhi Airport Metro Express Pvt. Ltd. (DAMEPL) has moved the Delhi High Court seeking execution of the Arbitration award it had won against Delhi Metro Rail Corporation (DMRC)," the company said in its filing.

The arbitral award was recently upheld by a single judge bench of the Delhi High Court.

In its petition filed under section 36 of the Arbitration and Conciliation Act in the division bench headed by Chief Justice of Delhi HC, DAMEPL has sought an order for the execution of the award dated May 11, 2017 passed by the Arbitral Tribunal and direct DMRC to pay a around Rs 5,200 crore, the company said.